In 2020, the market scale of Chinese traditional medicine will reach 580.6 billion yuan, and enterprises will push forward modernization development

The novel coronavirus epidemic has developed, and Chinese medicine has attracted attention as a treatment It is reported that as of February 17, 85.20% of the confirmed cases were treated with TCM It is understood that due to the factors such as the increase of demand, the limitation of logistics and the decrease of imports, there is an obvious upward trend in the Chinese herbal medicine market in the near future However, due to the delayed opening of the market, the current price is mainly the quotation rather than the actual transaction price As an important part of China's pharmaceutical industry, traditional Chinese medicine industry is one of the important national industries, which is of great significance in the overall economic and social development According to the data, the market scale of Chinese traditional medicine in 2015 was 391.8 billion yuan, accounting for 32.1% of the Chinese medicine market From 2011 to 2015, the compound growth rate of Chinese traditional medicine market scale was 16.8%, far higher than the growth rate of GDP From 2016 to 2020, the Chinese traditional medicine industry will continue to develop rapidly By 2020, the market size will reach 580.6 billion yuan, with a compound growth rate of 8.2% In the view of the insiders, while the important role of traditional Chinese medicine is further defined, the industry standard of traditional Chinese medicine will be improved, and the industry will face a painful period of transformation and upgrading in the short and medium term, which is conducive to the development of high-quality traditional Chinese medicine enterprises in the long term It is understood that while promoting the development of traditional Chinese medicine industry, some enterprises began to focus on quality and strive to push national medicine brands to the world stage For example, the person in charge of an enterprise said that the company actively implemented the new development concept, accelerated the transformation to the great health of traditional Chinese medicine, and paid more attention to the product efficacy The road of high quality and benefiting the people became wider and wider, and ran out of the "acceleration" of the high quality development of traditional Chinese medicine In the context of the implementation of the "healthy China strategy", traditional Chinese medicine ushers in a broader development space To promote the modernization of traditional Chinese medicine is not only the sacred mission given to us by history, but also the urgent need of enterprise transformation and development In order to better promote the development of traditional Chinese medicine industry, some traditional Chinese medicine enterprises continue to strengthen the research and development of new products of traditional Chinese medicine For example, a Chinese Medicine Research Institute of an enterprise has a research team of more than 100 people, including more than 80% of those with master's degree or above, and 4 academicians as intellectual support By virtue of high-quality clinical research, many products have been promoted to enter the national medical insurance drug catalog and national essential drug catalog For a long time, traditional Chinese medicine has many problems, such as uncontrollable quality, difficult to unify standards, unstable curative effect, and inconvenient to take In order to better promote the product reform, now some enterprises also continue to break through the standardization development of traditional Chinese medicine For example, an enterprise actively connects with the national strategy, and the declared national high-tech industry standardization pilot project of TCM process intelligent manufacturing is selected into the "national high-tech industry standardization pilot project" They have also undertaken the research work of 15 Monographs on Chinese herbal medicine European Pharmacopoeia, and independently researched varieties such as Hydrangea, Polygonum cuspidatum, Houttuynia cordata and zeylang have been included in European Pharmacopoeia, making pioneering contributions to the internationalization of Chinese herbal standards Some insiders said that without standardization, it means it is difficult to do large-scale Therefore, to find an innovation point, and try to achieve standardization, has become the key to break the situation In order to realize modernization and new breakthrough of traditional Chinese medicine industry, the whole transformation and upgrading from R & D, brand to production should be realized With the implementation of the "healthy China" strategy, the enterprises that are committed to promoting the modernization of traditional Chinese medicine have ushered in new opportunities
"The modernization of traditional Chinese medicine is to improve the development of traditional Chinese medicine to modern Chinese medicine The modernization of traditional Chinese medicine comes from the experience and clinical practice of traditional Chinese medicine Relying on modern advanced scientific and technological means and abiding by strict standards, a new generation of traditional Chinese medicine with high quality, high efficiency, safety, stability, controllable quality and convenient use is developed, which conforms to and reaches the international mainstream The market standard can be widely circulated in the world " According to the person in charge of an enterprise, in response to this, the enterprise has formulated a "one body, two wings" big health development strategy, covering the big health industry chain of traditional Chinese medicine planting, modern Chinese medicine research and development, modern Chinese medicine production, biological preparation, health care products, medicine retail, traditional Chinese medicine diagnosis and treatment, forming modern Chinese medicine injection, modern Chinese medicine soft capsule, modern Chinese medicine granules, modern Chinese medicine formula Four dosage forms